Department of Urology, Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Department of Evidence-Based Medicine and Clinical Epidemiology, The Second Clinical College of Wuhan University, Center for Evidence-Based and Translational Medicine, Wuhan University, The Endourological Clinical Research Medical Center of Hubei Province, Wuhan, Hubei, P.R. China.
Department of Urology, National Urological Cancer Center, Peking University First Hospital, Institute of Urology, Peking University, Beijing, P.R. China.
J Evid Based Med. 2018 Feb;11(1):64-67. doi: 10.1111/jebm.12290.
Bladder cancer and benign prostatic hyperplasia have been two very common diseases among the elderly men, especially with the aging of the population in the world. We have designed a study to investigate the clinical effect of interventional therapy for plasmakinetic resection of the prostate and plasmakinetic resection of the bladder, which is called "BPSC" (The bladder cancer and benign prostatic hyperplasia study in Chinese population). The BPSC is not only a specific study, it is made up of many studies. In this article, we introduced the research background, source, name, study framework, study management and further direction of BPSC project. We hope this process will contribute to the growth of the database through sharing data and enriching the evidence of bladder cancer and benign prostatic hyperplasia in the Chinese population, thereby finally improving the accessibility of these important findings for doctors, researchers, and patients.
膀胱癌和良性前列腺增生是老年男性中非常常见的两种疾病，尤其是在世界人口老龄化的情况下。我们设计了一项研究，旨在调查等离子体前列腺切除术和等离子体膀胱切除术的介入治疗的临床效果，我们称之为“BPSC”（中国人群中的膀胱癌和良性前列腺增生研究）。BPSC 不仅是一项具体的研究，它由许多研究组成。在本文中，我们介绍了 BPSC 项目的研究背景、来源、名称、研究框架、研究管理和未来方向。我们希望通过分享数据来促进数据库的增长，并丰富中国人群中膀胱癌和良性前列腺增生的证据，从而最终提高这些重要发现对医生、研究人员和患者的可及性。
